GO:0005488 | binding | 32.62% (61/187) | 1.33 | 0.0 | 0.0 |
GO:0006270 | DNA replication initiation | 2.67% (5/187) | 6.37 | 0.0 | 0.0 |
GO:0006259 | DNA metabolic process | 6.95% (13/187) | 3.16 | 0.0 | 0.0 |
GO:0003677 | DNA binding | 8.02% (15/187) | 2.88 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 37.97% (71/187) | 0.86 | 0.0 | 3e-06 |
GO:0036094 | small molecule binding | 13.37% (25/187) | 1.69 | 0.0 | 1e-05 |
GO:0000166 | nucleotide binding | 12.3% (23/187) | 1.64 | 1e-06 | 2.9e-05 |
GO:1901265 | nucleoside phosphate binding | 12.3% (23/187) | 1.64 | 1e-06 | 2.9e-05 |
GO:0030554 | adenyl nucleotide binding | 10.7% (20/187) | 1.81 | 1e-06 | 3e-05 |
GO:1901363 | heterocyclic compound binding | 16.58% (31/187) | 1.36 | 1e-06 | 3.2e-05 |
GO:0097159 | organic cyclic compound binding | 16.58% (31/187) | 1.36 | 1e-06 | 3.2e-05 |
GO:0032559 | adenyl ribonucleotide binding | 10.7% (20/187) | 1.81 | 1e-06 | 3.9e-05 |
GO:0005524 | ATP binding | 10.7% (20/187) | 1.82 | 1e-06 | 3.9e-05 |
GO:0003676 | nucleic acid binding | 9.63% (18/187) | 1.85 | 3e-06 | 5.5e-05 |
GO:0043168 | anion binding | 11.76% (22/187) | 1.59 | 4e-06 | 7.1e-05 |
GO:0097367 | carbohydrate derivative binding | 11.23% (21/187) | 1.62 | 5e-06 | 8.4e-05 |
GO:0005515 | protein binding | 13.9% (26/187) | 1.4 | 6e-06 | 9.3e-05 |
GO:0043167 | ion binding | 13.9% (26/187) | 1.35 | 1.2e-05 | 0.000155 |
GO:0044260 | cellular macromolecule metabolic process | 10.16% (19/187) | 1.64 | 1.3e-05 | 0.000155 |
GO:0017076 | purine nucleotide binding | 10.7% (20/187) | 1.58 | 1.4e-05 | 0.000159 |
GO:0032555 | purine ribonucleotide binding | 10.7% (20/187) | 1.58 | 1.3e-05 | 0.000162 |
GO:0035639 | purine ribonucleoside triphosphate binding | 10.7% (20/187) | 1.59 | 1.2e-05 | 0.000163 |
GO:0032553 | ribonucleotide binding | 10.7% (20/187) | 1.55 | 1.7e-05 | 0.000191 |
GO:0090304 | nucleic acid metabolic process | 6.95% (13/187) | 2.02 | 2.3e-05 | 0.000237 |
GO:0006269 | DNA replication, synthesis of RNA primer | 1.07% (2/187) | 7.05 | 5.7e-05 | 0.000575 |
GO:0030983 | mismatched DNA binding | 1.6% (3/187) | 5.17 | 6.7e-05 | 0.000653 |
GO:0006298 | mismatch repair | 1.6% (3/187) | 5.05 | 8.9e-05 | 0.000834 |
GO:0051128 | regulation of cellular component organization | 1.6% (3/187) | 4.93 | 0.000115 | 0.001039 |
GO:0003896 | DNA primase activity | 1.07% (2/187) | 6.46 | 0.00017 | 0.001479 |
GO:0006260 | DNA replication | 2.14% (4/187) | 3.72 | 0.000235 | 0.001973 |
GO:0006139 | nucleobase-containing compound metabolic process | 7.49% (14/187) | 1.57 | 0.000288 | 0.002345 |
GO:0016779 | nucleotidyltransferase activity | 2.67% (5/187) | 3.1 | 0.0003 | 0.002359 |
GO:0006275 | regulation of DNA replication | 1.07% (2/187) | 6.05 | 0.000339 | 0.002586 |
GO:0010639 | negative regulation of organelle organization | 1.07% (2/187) | 5.72 | 0.000562 | 0.003825 |
GO:0051129 | negative regulation of cellular component organization | 1.07% (2/187) | 5.72 | 0.000562 | 0.003825 |
GO:0046483 | heterocycle metabolic process | 7.49% (14/187) | 1.49 | 0.000529 | 0.003919 |
GO:0006725 | cellular aromatic compound metabolic process | 7.49% (14/187) | 1.48 | 0.000545 | 0.003922 |
GO:1901360 | organic cyclic compound metabolic process | 7.49% (14/187) | 1.46 | 0.00064 | 0.004243 |
GO:0006281 | DNA repair | 2.67% (5/187) | 2.83 | 0.000715 | 0.004619 |
GO:0033554 | cellular response to stress | 2.67% (5/187) | 2.77 | 0.000865 | 0.005191 |
GO:0006974 | cellular response to DNA damage stimulus | 2.67% (5/187) | 2.77 | 0.000865 | 0.005191 |
GO:0051716 | cellular response to stimulus | 2.67% (5/187) | 2.77 | 0.000865 | 0.005191 |
GO:0140097 | catalytic activity, acting on DNA | 2.14% (4/187) | 3.19 | 0.000981 | 0.005748 |
GO:0003887 | DNA-directed DNA polymerase activity | 1.6% (3/187) | 3.88 | 0.001092 | 0.006256 |
GO:0010564 | regulation of cell cycle process | 1.07% (2/187) | 5.24 | 0.001168 | 0.006538 |
GO:0034061 | DNA polymerase activity | 1.6% (3/187) | 3.82 | 0.001217 | 0.006665 |
GO:0006950 | response to stress | 2.67% (5/187) | 2.64 | 0.001288 | 0.006906 |
GO:0043170 | macromolecule metabolic process | 10.16% (19/187) | 1.1 | 0.001514 | 0.007951 |
GO:0034641 | cellular nitrogen compound metabolic process | 7.49% (14/187) | 1.3 | 0.001808 | 0.009296 |
GO:0005634 | nucleus | 2.14% (4/187) | 2.94 | 0.001874 | 0.009442 |
GO:0003690 | double-stranded DNA binding | 1.6% (3/187) | 3.54 | 0.002149 | 0.010621 |
GO:0050896 | response to stimulus | 2.67% (5/187) | 2.46 | 0.002225 | 0.010784 |
GO:0033043 | regulation of organelle organization | 1.07% (2/187) | 4.72 | 0.002465 | 0.011719 |
GO:0051726 | regulation of cell cycle | 1.07% (2/187) | 4.46 | 0.003579 | 0.016702 |
GO:0009059 | macromolecule biosynthetic process | 3.21% (6/187) | 1.99 | 0.004166 | 0.01909 |
GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0016728 | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0051095 | regulation of helicase activity | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0051097 | negative regulation of helicase activity | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0061731 | ribonucleoside-diphosphate reductase activity | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0046073 | dTMP metabolic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:1905462 | regulation of DNA duplex unwinding | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0009177 | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0043462 | regulation of ATPase activity | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0019692 | deoxyribose phosphate metabolic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0042083 | 5,10-methylenetetrahydrofolate-dependent methyltransferase activity | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0046385 | deoxyribose phosphate biosynthetic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0050797 | thymidylate synthase (FAD) activity | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0032780 | negative regulation of ATPase activity | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0042555 | MCM complex | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:1905463 | negative regulation of DNA duplex unwinding | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:1905774 | regulation of DNA helicase activity | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0032886 | regulation of microtubule-based process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0036038 | MKS complex | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0046605 | regulation of centrosome cycle | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0010826 | negative regulation of centrosome duplication | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0046606 | negative regulation of centrosome cycle | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0010824 | regulation of centrosome duplication | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0004797 | thymidine kinase activity | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0019136 | deoxynucleoside kinase activity | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0006231 | dTMP biosynthetic process | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:1905775 | negative regulation of DNA helicase activity | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0019206 | nucleoside kinase activity | 0.53% (1/187) | 7.05 | 0.00757 | 0.019667 |
GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups | 1.07% (2/187) | 3.88 | 0.008053 | 0.020708 |
GO:0016740 | transferase activity | 6.95% (13/187) | 1.09 | 0.008437 | 0.021476 |
GO:0048519 | negative regulation of biological process | 1.07% (2/187) | 3.8 | 0.008956 | 0.02257 |
GO:0043227 | membrane-bounded organelle | 2.14% (4/187) | 2.52 | 0.005294 | 0.023405 |
GO:0043231 | intracellular membrane-bounded organelle | 2.14% (4/187) | 2.52 | 0.005294 | 0.023405 |
GO:0048523 | negative regulation of cellular process | 1.07% (2/187) | 4.14 | 0.00561 | 0.024373 |
GO:0044237 | cellular metabolic process | 10.7% (20/187) | 0.87 | 0.006916 | 0.029538 |
GO:0030031 | cell projection assembly | 0.53% (1/187) | 6.05 | 0.015083 | 0.033938 |
GO:0120031 | plasma membrane bounded cell projection assembly | 0.53% (1/187) | 6.05 | 0.015083 | 0.033938 |
GO:0032954 | regulation of cytokinetic process | 0.53% (1/187) | 6.05 | 0.015083 | 0.033938 |
GO:0120036 | plasma membrane bounded cell projection organization | 0.53% (1/187) | 6.05 | 0.015083 | 0.033938 |
GO:0060271 | cilium assembly | 0.53% (1/187) | 6.05 | 0.015083 | 0.033938 |
GO:0010948 | negative regulation of cell cycle process | 0.53% (1/187) | 6.05 | 0.015083 | 0.033938 |
GO:2001251 | negative regulation of chromosome organization | 0.53% (1/187) | 6.05 | 0.015083 | 0.033938 |
GO:1901891 | regulation of cell septum assembly | 0.53% (1/187) | 6.05 | 0.015083 | 0.033938 |
GO:0044782 | cilium organization | 0.53% (1/187) | 6.05 | 0.015083 | 0.033938 |
GO:0009262 | deoxyribonucleotide metabolic process | 0.53% (1/187) | 6.05 | 0.015083 | 0.033938 |
GO:0030030 | cell projection organization | 0.53% (1/187) | 6.05 | 0.015083 | 0.033938 |
GO:0032955 | regulation of division septum assembly | 0.53% (1/187) | 6.05 | 0.015083 | 0.033938 |
GO:0043229 | intracellular organelle | 2.67% (5/187) | 1.77 | 0.015949 | 0.035569 |
GO:0043226 | organelle | 2.67% (5/187) | 1.76 | 0.016603 | 0.036701 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 1.07% (2/187) | 3.29 | 0.017671 | 0.038722 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 0.53% (1/187) | 5.46 | 0.02254 | 0.04336 |
GO:0009123 | nucleoside monophosphate metabolic process | 0.53% (1/187) | 5.46 | 0.02254 | 0.04336 |
GO:0006220 | pyrimidine nucleotide metabolic process | 0.53% (1/187) | 5.46 | 0.02254 | 0.04336 |
GO:0033293 | monocarboxylic acid binding | 0.53% (1/187) | 5.46 | 0.02254 | 0.04336 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 0.53% (1/187) | 5.46 | 0.02254 | 0.04336 |
GO:0051346 | negative regulation of hydrolase activity | 0.53% (1/187) | 5.46 | 0.02254 | 0.04336 |
GO:0008658 | penicillin binding | 0.53% (1/187) | 5.46 | 0.02254 | 0.04336 |
GO:0008144 | drug binding | 0.53% (1/187) | 5.46 | 0.02254 | 0.04336 |
GO:0051494 | negative regulation of cytoskeleton organization | 0.53% (1/187) | 5.46 | 0.02254 | 0.04336 |
GO:0019205 | nucleobase-containing compound kinase activity | 0.53% (1/187) | 5.46 | 0.02254 | 0.04336 |
GO:0043086 | negative regulation of catalytic activity | 0.53% (1/187) | 5.46 | 0.02254 | 0.04336 |
GO:0044092 | negative regulation of molecular function | 0.53% (1/187) | 5.46 | 0.02254 | 0.04336 |
GO:0004842 | ubiquitin-protein transferase activity | 1.07% (2/187) | 3.19 | 0.020239 | 0.043593 |
GO:0019787 | ubiquitin-like protein transferase activity | 1.07% (2/187) | 3.19 | 0.020239 | 0.043593 |
GO:0097747 | RNA polymerase activity | 1.07% (2/187) | 3.14 | 0.021579 | 0.045696 |
GO:0034062 | 5'-3' RNA polymerase activity | 1.07% (2/187) | 3.14 | 0.021579 | 0.045696 |
GO:0005622 | intracellular anatomical structure | 2.67% (5/187) | 1.61 | 0.024988 | 0.047705 |